
A tumor that develops in the nasal cavity is called olfactory neuroblastoma, also known as esthesioneuroblastoma. The sensation of smell is produced by neurons and other tissue in the nasal cavity. This kind of tumor begins in the nasal cavity and can grow into the nearby eyes and brain. Olfactory neuroblastoma can potentially extend to other regions of the body, including the neck, lungs, and bones.
The following warning signs and symptoms could be markers of olfactory neuroblastoma. Watery eyes, nosebleeds, congestion or stuffiness that worsens or persists, nose obstruction, postnasal drip, or nasal discharge in the throat, and eye pain, pus from the nose, numbness in the face or teeth, loose teeth, diminished smell, or changes in eyesight, • Problem opening the mouth; • Pain or pressure in the ears; • Enlarged neck lymph nodes
Symptoms of olfactory neuroblastoma include:
Causes
The precise cause of olfactory neuroblastoma has not been determined by experts. Generally speaking, DNA alterations in cells cause cancer. The instructions that inform a cell what to do are encoded in its DNA. The modifications instruct the cells to rapidly produce a large number of new cells. When healthy cells would normally die, the alterations allow the cells to survive. Too many cells are produced as a result.
The cells may accumulate into a mass known as a tumor. Healthy body tissue may be invaded and destroyed by the tumor as it grows. Cells may eventually separate and disperse throughout the body.
Risk Factors
It is thought to be a major risk factor to work in areas where one is exposed to wood dust, metal dusts (nickel, cadmium), wheat, glues, formaldehyde, and other solvents. Olfactory neuroblastoma risk may also be raised by exposure to tobacco smoke.
Complications
The complications of Olfactory Neuroblastoma include:
By combining surgery and radiation therapy, Thailand has achieved notable progress in the treatment of olfactory neuroblastoma. Prominent medical facilities use cutting-edge endoscopic surgical methods to remove tumors precisely, lowering risks and enhancing patient results. Modern imaging techniques, such as PET-CT and MRI scans, help with precise diagnosis and therapy planning. Personalized care is ensured by a multidisciplinary strategy that includes radiologists, neurosurgeons, and oncologists.
Although the precise origin of olfactory neuroblastoma is unknown, evidence points to a possible connection with chemical exposure. People who are exposed to dangerous chemicals and particles at work or through other activities are more likely to develop malignancies of the nasal cavity, according to research. Wood dust, wheat, glues, nickel and cadmium dust, formaldehyde, and other solvents are a few potential offenders. The development of an olfactory neuroblastoma may potentially be influenced by tobacco smoke. Steer clear of these chemicals as much as you can to protect yourself.
Chemotherapy: Chemotherapy may be used in situations when the tumor has migrated to other body areas. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin.Typically, chemotherapy is a systemic treatment. This implies that the medications enter the bloodstream and travel throughout the body to kill cancer cells, including ones that may have separated from the main tumor. The medications can be administered intravenously (IV) or orally. The medications may occasionally be administered safely using a specialized tool known as a central venous catheter. When chemotherapy begins, it is often implanted during surgery and kept there until the end of the course of treatment.
Cost Start From USD 1000 - USD 6800Explore Options
Radiation therapy: Some olfactory neuroblastoma tumors may be treated with radiation therapy. Radiation therapy may be used as the primary treatment or to help lower the likelihood of tumor recurrence following surgery. The success rates for radiation therapy are 90–95% in stage I, 85–90% in stage II, and 75–80% in stage III. The patient is recommended to see the doctor for follow-up every three months following radiation therapy.
Olfactory neuroblastoma is diagnosed by examining the nasal cavity using a number of various scanning techniques. These consist of MRIs, CT scans, and X-rays. A biopsy may be performed by a physician to obtain further information. To ascertain the type of cancer present, a tissue sample is taken and examined under a microscope.
Since neuroblastoma occurs near important structures, patients may require rehab for the following reasons.
Patients may experience changes in their sense of smell due to the tumor's proximity to the olfactory nerves, necessitating olfactory training or adaption techniques. Dryness in the nasal passages is one of the adverse effects of radiation therapy that may necessitate the adoption of extra management techniques. exercises to enhance the function of the muscles of the face, control pain, and encourage the repair of soft tissues. addressing any speech issues that can result from the disruption of surrounding structures after surgery. activities that aid in retraining the sense of smell, if it has been severely compromised. Advice on controlling nutritional requirements in light of possible swallowing issues
The only treatment option is surgery, radiation therapy, and chemotherapy. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin.









Bangkok, Thailand
Bangkok Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Thailand:
Due to advancements in medical facilities, such as minimally invasive surgical techniques.
Yes, a group of specialists including radiation oncologists, neurosurgeons, and head and neck surgeons collaborate to create a customized treatment plan for each patient. With treatment, the majority of patients with olfactory neuroblastoma recover.
With skilled neurosurgeons, oncologists and cutting-edge medical technology, Thailand has demonstrated significant success rates in treating olfactory neuroblastoma. The nation's healthcare institutions offer top-notch treatment alternatives, guaranteeing successful outcomes for many patients.
Yes, many Thailand hospitals offer the following for olfactory neuroblastoma treatment:
Always consider the following factors when selecting Thailand hospitals:
In general, olfactory neuroblastoma treatment has much improved in Thailand. The success rate largely depends on how early diagnosis is made. The 5-year overall survival for olfactory neuroblastoma has been reported to be between 70% to 90%, indicating a positive long-term survival rate. Recurrence is common, though, with a 10-year disease-free survival rate recorded.
You need to keep an eye out for the following signs in them:
Patients with Olfactory Neuroblastoma may experience long-term consequences such as irreversible loss of smell (anosmia), changes in vision, cognitive impairment, and the possibility of spread of tumor to other parts of the body.
Yes, you can see top neuro hospitals and doctors in Thailand for a second opinion on Seizures treatment. Numerous prestigious medical facilities consult with skilled doctors who will examine your diagnosis and suggest the best course of action.